Trulieve Reports Q3 2025 Revenue of $288.2 Million, Income from Operations Improves

Trulieve Cannabis Corp. reported its financial results for the third quarter of 2025, revealing a revenue of $288.2 million, a slight increase of 1.4% from $284.3 million in the same period last year. The company's gross profit for the quarter was $169.9 million, down 2% from $173.3 million year-over-year, reflecting a gross margin of 58.9%. The cost of goods sold rose to $118.3 million, up 7% from the previous year, primarily due to price compression in the market. Despite these challenges, Trulieve's income from operations significantly improved to $42.2 million, compared to just $0.6 million in the prior year, indicating a strategic focus on cost management.

In terms of overall financial performance for the nine months ending September 30, 2025, Trulieve reported total revenue of $888 million, a marginal increase from $885.3 million in the same period of 2024. The company experienced a notable increase in wholesale revenue, which rose by $9.6 million, although retail revenue decreased by $6.9 million due to price pressures. The net loss from continuing operations was reported at $71.7 million, a 24% improvement compared to a loss of $94.4 million in the previous year, showcasing the company's efforts to enhance operational efficiency.

Strategically, Trulieve has continued to expand its market presence, operating 232 dispensaries across nine states, including significant operations in Florida, Arizona, and Pennsylvania. The company has also launched new product lines, including THC beverages, which are part of its strategy to diversify its offerings and attract a broader customer base. The filing noted that the company is focused on enhancing its retail and wholesale operations, which have been bolstered by new store openings and adult-use sales in Ohio.

Operationally, Trulieve reported a decrease in selling, general, and administrative expenses, which fell to $99 million from $148.6 million year-over-year, largely due to reduced campaign contributions and general operating cost management. The company’s cash and cash equivalents increased to $449.2 million as of September 30, 2025, up from $238.8 million at the end of 2024, providing a solid liquidity position to support ongoing operations and potential future investments.

Looking ahead, Trulieve remains optimistic about its growth trajectory, emphasizing its commitment to expanding its market share and enhancing customer experiences. The company plans to continue investing in its infrastructure and product offerings while navigating the complexities of the cannabis market, which remains subject to regulatory challenges. Trulieve's management believes that its current cash reserves will be sufficient to meet anticipated cash requirements for at least the next 12 months, positioning the company for continued operational stability and growth.